ClinicalTrials.gg
Status unknownNCT01373697Updated Jun 15, 2011

Study to Assess the Efficacy and Safety of Ibuprofen 50 mg/g Gel Compared to Profenid 25mg/g Gel

A Phase 3 interventional study of Ibuprofen and Profenid in Muscular Atrophy, Sprains and Tendonitis, sponsored by Laboratório Teuto Brasileiro S/A. Status unknown at 1 site in Brazil. Open to participants aged 12 Years to 65 Years. Per ClinicalTrials.gov, last updated 2011-06-15.

Sponsored by Laboratório Teuto Brasileiro S/A · Phase 3, Interventional, and Treatment

How we know

The sponsor has not verified this record recently (last verified Jun 2011), so the status shown — last known as Not yet recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
144
Allocation
Randomized
Ages
12 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-20

Among 18 studies in Muscular Atrophy with a site in Brazil — 6 open to participants now, 7 under way, 1 of them phase 3. Muscular Atrophy · Brazil.

Planned enrollment
Largest of 14
144 · median 33
Started
2011
the only one that year
Phase 3
3 of 18
none open now
Registered
1st of 18
by date
Lead sponsor
1 of 18
Laboratório Teuto Brasileiro S/A

Among the 18 studies in Muscular Atrophy with a site in Brazil, this one has the largest planned enrollment of the 14 interventional ones that give a count, is the only one that started in 2011, is one of 3 in phase 3, and was the 1st registered.

Muscular Atrophy

413 studies on the registry are indexed under Muscular Atrophy; 77 are open to participants now.

Browse Muscular Atrophy studies →

Open to participants now

6 of the 18 studies in Muscular Atrophy with a site in Brazil are open now. Recruiting first, the newest first:

1 more — sign in →

All 6 open studies →

A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →

Who these studies take

Of the 52 Muscular Atrophy studies recruiting now, 25 (48%) set no upper age limit and 13 (25%) stop at 75 or younger; 4 take children under 18; 17 take healthy volunteers.

This study: 12 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Muscular Atrophy with a site in Brazil, or all of them as a file.
02

Study summary

The aim of this study is to determine that ibuprofen 50mg/g gel is effective and safety treating patients with muscle aches, joint pains or due to sprains, bruises, tendinitis or myofascial compared to Profenid 25mg/g gel.

Read the detailed description

The main objective of this study is to evaluate the efficacy of ibuprofen 50 mg/g gel in the treatment of patients with muscle, joint pain caused by sprains, contusions, tendinitis, or myofascial compared to Profenid 25mg/g gel.

03

Conditions studied

  • Muscular Atrophy
  • Sprains
  • Tendonitis

Keywords

  • Ibuprofen
  • muscle pain
  • sprains
  • contusions
  • tendonitis
04

Who can participate

Ages eligible
12 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients of both sexes, of any race, aged 12 years;
  • Ability to read, understand and sign the in the case of minors monitoring and consent of a parent;
  • Complaint of clinical muscle pain, joint pain caused by sprains, contusions, tendonitis, or myofascial;
  • Score more than 4 VAS symptom reviewed: Pain;
  • Patients able to understand and follow the protocol of the trial.
  • Patients with or without ligament injury ligament injury partial and incomplete

Exclusion criteria

Exclusion Criteria:

  • Known to components of the formula, both the medication and the comparative test;
  • Hypersensitivity to acetylsalicylic acid;
  • Hypersensitivity to ketoprofen, ibuprofen or other anti-inflammatory ;
  • Hypersensitivity to acetaminophen;
  • Skin changes in the pathological site of application, such as eczema or acne, or infected skin or wound;
  • Pregnant or lactating women.
  • Patients who require surgery or immobilization;
  • Patients with fractures or ligament rupture;
  • Patients taking anticoagulants;
  • Patients with decompensated concomitant systemic diseases, such as diabetes, congenital or acquired blood disorders, convulsive disorders, diseases, renal failure, severe infections, hormonal disorders and pulmonary disorders;
  • Use of NSAIDs, corticosteroids or venotherapics, threads or any other form of administration;
  • History of alcoholism or substance abuse;
  • Conditions in the opinion of the investigator make the patient unsuitable to participate in the study.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
144 participants (estimated)

Study arms

  • Active comparator
    Profenid

    Apply the gel on the spot of pain or injury, massaging slightly to facilitate the penetration of 8 in 8 hours during 5 days. Leave the gel on the the site at least 4 hours before removal

    Drug: Profenid

  • Active comparator
    Ibuprofen

    Apply the gel on the spot of pain or injury, massaging slightly to facilitate the penetration of 8 in 8 hours during 5 days. Leave the gel on the the site at least 4 hours before removal

    Drug: Ibuprofen

Interventions

  • Apply the gel at the site of pain or injury, massaging gently to promote penetration of 8 in 8 hours for 5 days. Leave the gel on the premises at least 4 hours before removal

  • DrugKetoprofenStudies of KetoprofenKetoprofen pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Apply the gel on the spot of pain or injury, massaging slightly to facilitate the penetration of 8 in 8 hours during 5 days. Leave the gel on the the site at least 4 hours before removal

06

What researchers measure

Primary outcomes

  1. Clinical study evaluating the efficacy and safety of Ibuprofen 50mg / g gel in the treatment of patients with muscle pain, joint, or pain caused by sprains, contusions, tendinitis, or myofascial compared to Profenid ® 25mg / g gel. "

    To evaluate the efficacy of ibuprofen 50 mg / g gel in the treatment of patients with muscle aches, joint pains or due to sprains, bruises, tendinitis or myofascial compared with Profenid® Gel 25mg / g, will be used two methods. 1. the visual analog scale (VAS)and 2. investigator's opinion to measure before and after treatment comparing the decrease of the symptoms. The study will have 144 patients to be included with any sex or race, minimum age 12 years.

    Time frame: five days

Secondary outcomes

  1. Clinical study evaluating the tolerability of Ibuprofen 50mg / g gel in the treatment of patients with muscle pain, joint, or pain caused by sprains, contusions, tendinitis, or myofascial compared to Profenid ® 25mg / g gel. "

    To evaluate the tolerability of ibuprofen 50 mg / g gel in the treatment of patients with muscle aches, joint pains or due to sprains, bruises, tendinitis or myofascial compared with Profenid ® Gel 25mg / g will be use a measure using Naranjo algorithm to determinate the causality of the events.

    Time frame: five days

07

Study locations

1 site
  • ABC School of Medicine
    São Paulo, 09060-650, Brazil
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jun 2011, a primary completion of Aug 2011 and a completion of Aug 2011. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 22, 2011
First posted
Jun 15, 2011
Start
Jun 2011
Primary completionEst.
Aug 2011
CompletionEst.
Aug 2011
Last update
Jun 15, 2011
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 15, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01373697
Lead sponsor
Laboratório Teuto Brasileiro S/A
First posted
Jun 15, 2011
Start date
Jun 2011
Primary completion
Aug 2011 (estimated)
Completion
Aug 2011 (estimated)
Last update
Jun 15, 2011

Study contacts

Abel Pereira, researcher
Contact
abelpsjr@terra.com.br
11 55 4993-5459
Thabata Veiga, coordinator
Contact
thabataveiga.pesquisa@yahoo.com.br
11 55 4993-5459
Abel Pereira, investigator
principal investigator · ABC School Medicine

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Ibuprofen · Ketoprofen

Start the discussion